Cancer
Malignant Bladder Neoplasm
CI-CAN-00005866Explore in graph →
Top-level347 active trials10 approved drugs26 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005866Explore in graph →
Clinical trials
1,512 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (179)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01391143 | Safety Study of MGA271 in Refractory Cancer | completed | Phase 1 | 179 | MacroGenicsINDUSTRY | 1 | Feb 8, 2022 | clinicaltrials |
| NCT02628535 | Safety Study of MGD009 in B7-H3-expressing Tumors | terminated | Phase 1 | 67 | MacroGenicsINDUSTRY | 3 | Feb 8, 2022 | clinicaltrials |
| NCT05220124 |
| unknown |
| Phase 4 |
| 190 |
| Tianjin Medical University Second HospitalOTHER |
| 1 |
| Feb 2, 2022 |
| clinicaltrials |
| NCT05180851 | Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study(YSCH-01) | unknown | Early Phase 1 | 28 | Shanghai Fengxian District Central HospitalOTHER | 1 | Feb 1, 2022 | clinicaltrials |
| NCT04316689 | First-in-human Study of S-588210 (S-488210+S-488211) | completed | Phase 1 | 10 | ShionogiINDUSTRY | 1 | Jan 26, 2022 | clinicaltrials |
| NCT04947059 | Effectiveness of an Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin in Patients With Urinary Bladder Cancer (Gemcitabine Epirubicin Normal SAline)(GENSA) | recruiting | Phase 3 | 180 | University of ThessalyOTHER | 1 | Jan 26, 2022 | clinicaltrials |
| NCT01935466 | Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy "PROBE"(PROBE-PIO) | completed | — | 6,107 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Jan 25, 2022 | clinicaltrials |
| NCT02992990 | Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade | unknown | N/A | 30 | Baylor College of MedicineOTHER | 1 | Jan 19, 2022 | clinicaltrials |
| NCT05108077 | Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells | unknown | Phase 1 / Phase 2 | 20 | Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusOTHER_GOV | 1 | Jan 14, 2022 | clinicaltrials |
| NCT03715985 | Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac)(NeoPepVac) | unknown | Phase 1 / Phase 2 | 12 | Herlev HospitalOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT05146635 | Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial | unknown | N/A | 110 | Mansoura UniversityOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT05072600 | Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer | recruiting | Phase 2 | 54 | Peking University First HospitalOTHER | 1 | Jan 10, 2022 | clinicaltrials |
| NCT02966691 | Evaluation of Diagnostic Performance of VisioCyt® Test, in Case of Suspicion of Urothelial Bladder Tumors(VISIOCYT 1) | completed | N/A | 1,360 | VitadxOTHER | 1 | Jan 6, 2022 | clinicaltrials |
| NCT03689478 | Use of Immediate Hyperthermic Intravesical Chemotherapy Following TURBT(I-HIVEC) | completed | N/A | 30 | Chinese University of Hong KongOTHER | 1 | Jan 3, 2022 | clinicaltrials |
| NCT02001623 | Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 195 | Seagen Inc.INDUSTRY | 5 | Dec 29, 2021 | clinicaltrials |
| NCT05167916 | Can Four Weeks-check Cystoscopy and Urine Cytology After Primary Complete Resection of T1 Bladder Cancer Replace Repeat Biopsy? | unknown | N/A | 200 | Mansoura UniversityOTHER | 1 | Dec 22, 2021 | clinicaltrials |
| NCT03801278 | An Expanded Access Study of Bemarituzumab (FPA144) for a Single Patient With Recurrent Bladder Cancer(FPA144) | no longer available | — | — | Five Prime Therapeutics, Inc.INDUSTRY | 0 | Dec 13, 2021 | clinicaltrials |
| NCT05148728 | Active Surveillance vs in Office Fulguration for Low Grade Bladder Cancer Tumors | unknown | N/A | 120 | Vall Hebron Insitut RecercaNETWORK | 1 | Dec 8, 2021 | clinicaltrials |
| NCT03430895 | Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract | completed | Phase 2 | 15 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 1, 2021 | clinicaltrials |
| NCT02767921 | sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer | terminated | Phase 1 | 2 | University of Southern CaliforniaOTHER | 1 | Nov 24, 2021 | clinicaltrials |
| NCT03520231 | Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases | completed | Phase 2 | 6 | University Health Network, TorontoOTHER | 1 | Nov 23, 2021 | clinicaltrials |
| NCT05123404 | Validation of VI-RADS for the Detection of Detrusor Muscle Invasion | unknown | N/A | 60 | Egyptian Biomedical Research NetworkNETWORK | 1 | Nov 17, 2021 | clinicaltrials |
| NCT05112523 | The Performance of Cancer Risk Genes in the Necessity of Secondary TURBT(RE-TURBT) | unknown | — | 200 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Nov 9, 2021 | clinicaltrials |
| NCT04555343 | Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention | completed | Phase 1 / Phase 2 | 14 | Fraser HealthOTHER | 1 | Nov 5, 2021 | clinicaltrials |
| NCT03245736 | Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. | completed | Phase 2 | 5 | Seagen Inc.INDUSTRY | 2 | Nov 4, 2021 | clinicaltrials |
| NCT00318643 | Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer | completed | Phase 1 / Phase 2 | 27 | Halozyme TherapeuticsINDUSTRY | 1 | Oct 29, 2021 | clinicaltrials |
| NCT04730232 | Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable | unknown | Phase 2 | 63 | Tianjin Medical University Second HospitalOTHER | 1 | Oct 29, 2021 | clinicaltrials |
| NCT02792192 | Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants | terminated | Phase 1 / Phase 2 | 24 | Hoffmann-La RocheINDUSTRY | 1 | Oct 28, 2021 | clinicaltrials |
| NCT05097404 | Clinical Utility of VI-RADS in Diagnosis of MIBC | unknown | — | 73 | Samsung Medical CenterOTHER | 1 | Oct 28, 2021 | clinicaltrials |
| NCT02563561 | A Study of Intravesical Apaziquone as a Surgical Adjuvant in Participant Undergoing Transurethral Resection Bladder Tumor (TURBT) | terminated | Phase 3 | 62 | Spectrum Pharmaceuticals, IncINDUSTRY | 1 | Oct 27, 2021 | clinicaltrials |
| NCT05096533 | The Application Value of Artificial Intelligence in MRI Precision Diagnosis and Treatment of Bladder Cancer | unknown | — | 150 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Oct 27, 2021 | clinicaltrials |
| NCT01738815 | Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer | completed | Early Phase 1 | 43 | State University of New York - Upstate Medical UniversityOTHER | 1 | Oct 22, 2021 | clinicaltrials |
| NCT04273724 | Early Intervention for Impairments Identified During Comprehensive Geriatric Assessment in Patients With Bladder Cancer | terminated | N/A | 5 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Oct 18, 2021 | clinicaltrials |
| NCT04280640 | Relationship Between Circulating Tumor Cell Cultures' Treatment Response and Clinical Outcomes | withdrawn | — | 0 | UNC Lineberger Comprehensive Cancer CenterOTHER | 0 | Oct 18, 2021 | clinicaltrials |
| NCT04190641 | Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder | completed | N/A | 4 | Ambu A/SINDUSTRY | 1 | Oct 14, 2021 | clinicaltrials |
| NCT03091764 | Evaluation of a Patient-Reported Symptom Index for NMIBC | completed | — | 498 | University of SydneyOTHER | 5 | Oct 13, 2021 | clinicaltrials |
| NCT01776138 | Study of Outcomes After Surgery/Treatment to Treat Bladder Cancer(PORCH) | completed | — | 103 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Oct 6, 2021 | clinicaltrials |
| NCT04900259 | The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations | completed | — | 183 | Ankara Training and Research HospitalOTHER | 1 | Oct 6, 2021 | clinicaltrials |
| NCT03224182 | A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT) | terminated | Phase 3 | 118 | Spectrum Pharmaceuticals, IncINDUSTRY | 1 | Sep 28, 2021 | clinicaltrials |
| NCT05027412 | En Bloc TURBT With Collins Loop vs Conventional TURBT(TURBT) | unknown | N/A | 80 | Hospital Universitario de FuenlabradaOTHER | 1 | Aug 30, 2021 | clinicaltrials |
| NCT04256161 | Measurements of Sexual Steroids' Concentrations in Prostatic Tissue(Pré-HORM) | completed | — | 24 | Hopital FochOTHER | 1 | Aug 27, 2021 | clinicaltrials |
| NCT03864302 | Simulation in Transurethral Bladder Cancer Surgery(OSATURB) | unknown | N/A | 34 | Rigshospitalet, DenmarkOTHER | 1 | Aug 24, 2021 | clinicaltrials |
| NCT05018429 | Nerve Sparing Versus Non Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male | unknown | — | 100 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Aug 24, 2021 | clinicaltrials |
| NCT05016973 | A Clinical Study of RC48-ADC Combined With Triplizumab For Treatment of Myometrial Invasive Bladder Cancer | unknown | Phase 2 | 25 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Aug 23, 2021 | clinicaltrials |
| NCT04815629 | Outcome of Radiation Therapy in Urinary Bladder Squampus Cell Carcinoma | unknown | — | 40 | Assiut UniversityOTHER | 0 | Aug 18, 2021 | clinicaltrials |
| NCT00694915 | Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder(STCC) | completed | Phase 2 | 122 | Cadila PharnmaceuticalsINDUSTRY | 1 | Aug 17, 2021 | clinicaltrials |
| NCT01489800 | The Impact of Early Feeding After Radical Cystectomy for Bladder Cancer | completed | N/A | 102 | Columbia UniversityOTHER | 1 | Aug 17, 2021 | clinicaltrials |
| NCT01343121 | Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy(Gemtrans) | completed | N/A | 50 | The Christie NHS Foundation TrustOTHER | 1 | Aug 13, 2021 | clinicaltrials |
| NCT05001763 | Prucalopride for Postoperative Ileus in Patients Undergoing Robot-assisted Laparoscopic Radical Cystectomy | unknown | Phase 2 | 160 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 0 | Aug 12, 2021 | clinicaltrials |
| NCT04162704 | EpiCheck and Short-term Intensive Chemoresection in NMIBC | unknown | — | 22 | Aarhus University HospitalOTHER | 1 | Aug 11, 2021 | clinicaltrials |
Data updated 24 days agoSource updated Feb 8, 2022source: clinicaltrials